Sign in

CIK 0001668243

  • Non-accelerated filer
  • Smaller reporting company

UroGen Pharma Ltd.

Sign in to watch
Ticker
URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 97707601
Business address
9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$182,793
in 3 filings

Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-04 Schoenberg Mark Chief Medical Officer Exercise or conversion +1,042 5,652
2019-06-04 Schoenberg Mark Chief Medical Officer Shares withheld for taxes −343 $35.05 $12K 5,309
2019-06-04 Schoenberg Mark Chief Medical Officer Exercise or conversion · Restricted Stock Units (RSUs) −1,042 6,250
2019-06-03 Tomasello Shawn Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-03 FALBERG KATHRYN E Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-03 BUTITTA CYNTHIA M Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-03 Cohen Fred E Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-03 Nussbaum Ran Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-03 Holden Stuart Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-06-03 Belldegrun Arie Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2019-05-14 Mullennix Stephen Chief Operating Officer Exercise or conversion +1,759 5,989
2019-05-14 Mullennix Stephen Chief Operating Officer Sale −608 $37.98 $23K 5,381
2019-05-14 Mullennix Stephen Chief Operating Officer Exercise or conversion · Restricted Stock Units −1,759 12,314
2019-03-27 Belldegrun Arie Director Exercise or conversion +128,000 $4.02 $515K 212,211
2019-03-27 Belldegrun Arie Director Exercise or conversion · Stock Option (right to buy −128,000 $4.02 $515K 0
2019-03-21 Schoenberg Mark Chief Medical Officer Purchase +272 $37.01 $10K 4,610

Page 25 of 25 · 496 trades